EPA022 | Impact of chronic HIV infection on NK cell response through the HLA-E/NKG2x axis | E-poster | Innate immunity (including NK cells) |
EPA080 | Impact of chronic HCV infection on CD4-T cells permissiveness to HIV infection and viral reservoir persistence | E-poster | HIV and co-infections (TB, viral hepatitis, SARS-CoV2, other) |
EPD499 | Impact of antiretroviral treatment and treatment duration on incident pregnancy among HIV-positive women: evidence from population-based HIV impact assessments | E-poster | Sexual and reproductive health, fertility, family planning, pregnancy and abortion |
EPE196 | Impact of a One-Stop model and its contribution to early retention in Tete province, Mozambique | E-poster | Strategies to increase retention and re-engagement in HIV services |
EPE323 | Impact of a conditional cash transfer on AIDS incidence, hospitalizations and mortality in Brazil: a nationwide longitudinal study | E-poster | Social protection: New evidence and programmatic lessons |
OAB0403 | Impact of a community-wide HIV test and treat intervention on population-level tuberculosis transmission in rural Uganda | Oral abstract session with live Q&A | Tuberculosis: Prevention, diagnosis, treatment |
PESAE16 | Impact of a community health worker intervention on PrEP knowledge and utilization in Rakai, Uganda: a mixed methods assessment | Poster exhibition | Implementation science of scaling up prevention (including PrEP) |
EPD301 | Impact assessment of a Faith-based strategy for HIV mitigation in Nigeria | E-poster | Interventions to reduce stigma and discrimination |
EPA023 | Immunotherapeutic blockades targeting LAG-3 and PD-1 immune checkpoint inhibitors on invariant Natural Killer T cells: implications in chronic HIV infection | E-poster | Innate immunity (including NK cells) |
PEMOA36 | Immunogenicity of the BNT 162b2 mRNA vaccine against COVID-19 variants in people living with HIV on antiretroviral therapy in Malaysia | Poster exhibition | SARS-Cov2 vaccines |